Tuesday, April 21, 2026
Yahoo Finance

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

R
Redacción
Newsroom · anteayer
2 min read
H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating · DevFinanciero